Uncategorized
VIDEO: Ocular Therapeutix updates product pipeline
NEW YORK — From OSN New York 2018, Antony Mattessich, CEO of Ocular Therapeutix, discusses progress toward approval of the dexamethasone implant, Dextenza, as well as other products in the company’s pipeline.